Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

CAPS Rating: 2 out of 5

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

Recs

1
Player Avatar ayuddha (< 20) Submitted: 7/15/2012 5:18:50 PM : Outperform Start Price: $117.52 REGN Score: +95.59

It was picked by www.hechtsoft.de Trade Alerts.

Featured Broker Partners


Advertisement